Litcius/Paper detail

Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series

Gaetano Licata, Vittorio Tancredi, Elena Pezzolo, Ginevra Pertusi, Ersilia Tolino, Mariachiara Arisi, Alessio Gambardella

2023Journal of the European Academy of Dermatology and Venereology20 citationsDOI

Abstract

The data that support the findings of this study are openly available in Pubmed and Liebertpub at: (1) https://doi.org/10.1080/17512433.2018.1449642; (2) https://doi.org/10.1111/jdv.17705; (3) https://doi.org/10.1111/ijd.16022; (4) https://doi.org/10.1080/09546634.2022.2153578; (5) https://doi.org/10.1089/derm.2022.0063; (6) https://doi.org/10.1111/bjd.19574; (7) https://doi.org/10.1097/ICO.0000000000003162; (8) https://doi.org/10.1111/bjd.20810.

Topics & Concepts

DupilumabMedicineAtopic dermatitisDermatologyDermatology and Skin DiseasesUrticaria and Related ConditionsAllergic Rhinitis and Sensitization
Efficacy and safeness of tralokinumab in patients with atopic dermatitis who developed conjunctivitis under dupilumab: A case series | Litcius